Kia Washington
Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eye | 4 | 2016 | 108 | 2.150 |
Why?
| Facial Transplantation | 4 | 2022 | 10 | 1.730 |
Why?
| Blindness | 3 | 2016 | 35 | 1.700 |
Why?
| Tacrolimus | 5 | 2024 | 154 | 1.520 |
Why?
| Vascularized Composite Allotransplantation | 3 | 2023 | 21 | 1.380 |
Why?
| Vibrissae | 3 | 2022 | 12 | 1.130 |
Why?
| Myelin Sheath | 2 | 2024 | 149 | 0.890 |
Why?
| Nerve Regeneration | 6 | 2024 | 53 | 0.820 |
Why?
| Optic Nerve Injuries | 2 | 2017 | 4 | 0.760 |
Why?
| Tissue and Organ Harvesting | 2 | 2016 | 68 | 0.710 |
Why?
| Rats | 14 | 2024 | 5426 | 0.630 |
Why?
| Peripheral Nerve Injuries | 2 | 2018 | 33 | 0.580 |
Why?
| Organ Transplantation | 2 | 2016 | 165 | 0.580 |
Why?
| Somatosensory Cortex | 2 | 2022 | 38 | 0.560 |
Why?
| Transplantation, Homologous | 6 | 2020 | 413 | 0.550 |
Why?
| Neurons, Afferent | 1 | 2016 | 92 | 0.530 |
Why?
| Retina | 1 | 2016 | 277 | 0.490 |
Why?
| Composite Tissue Allografts | 2 | 2022 | 8 | 0.440 |
Why?
| Adaptation, Physiological | 1 | 2016 | 510 | 0.420 |
Why?
| Graft Rejection | 5 | 2022 | 556 | 0.410 |
Why?
| Surgery, Plastic | 2 | 2020 | 28 | 0.360 |
Why?
| Hindlimb | 5 | 2023 | 138 | 0.350 |
Why?
| Tissue Transplantation | 1 | 2009 | 12 | 0.350 |
Why?
| Craniofacial Abnormalities | 1 | 2009 | 66 | 0.330 |
Why?
| Animals | 18 | 2024 | 34133 | 0.310 |
Why?
| Neurons | 3 | 2024 | 1345 | 0.290 |
Why?
| Urethane | 1 | 2024 | 40 | 0.240 |
Why?
| Carbamates | 1 | 2024 | 38 | 0.240 |
Why?
| Urea | 1 | 2024 | 78 | 0.230 |
Why?
| Esters | 1 | 2024 | 60 | 0.230 |
Why?
| Facial Hemiatrophy | 1 | 2023 | 1 | 0.230 |
Why?
| Costal Cartilage | 1 | 2023 | 2 | 0.230 |
Why?
| Amides | 1 | 2024 | 88 | 0.230 |
Why?
| Tissue Scaffolds | 2 | 2023 | 195 | 0.230 |
Why?
| Physical Stimulation | 1 | 2022 | 80 | 0.220 |
Why?
| Free Tissue Flaps | 1 | 2023 | 32 | 0.220 |
Why?
| Thalamus | 1 | 2022 | 83 | 0.210 |
Why?
| Visual Pathways | 1 | 2022 | 45 | 0.210 |
Why?
| Manganese | 1 | 2022 | 57 | 0.210 |
Why?
| Skin Transplantation | 2 | 2014 | 57 | 0.210 |
Why?
| Rats, Inbred Lew | 6 | 2023 | 87 | 0.210 |
Why?
| Immunosuppressive Agents | 5 | 2023 | 687 | 0.210 |
Why?
| Surgical Flaps | 2 | 2014 | 119 | 0.190 |
Why?
| Rectus Abdominis | 1 | 2020 | 12 | 0.190 |
Why?
| Rats, Inbred BN | 5 | 2023 | 51 | 0.190 |
Why?
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2020 | 16 | 0.190 |
Why?
| Parental Leave | 1 | 2019 | 13 | 0.180 |
Why?
| Sexism | 1 | 2020 | 50 | 0.180 |
Why?
| Physicians, Women | 1 | 2019 | 53 | 0.170 |
Why?
| Family Planning Services | 1 | 2019 | 70 | 0.170 |
Why?
| Peripheral Nerves | 1 | 2018 | 65 | 0.160 |
Why?
| Career Choice | 1 | 2019 | 206 | 0.150 |
Why?
| Tissue Survival | 1 | 2016 | 13 | 0.150 |
Why?
| Recovery of Function | 2 | 2013 | 610 | 0.150 |
Why?
| Retinal Ganglion Cells | 1 | 2017 | 92 | 0.150 |
Why?
| Leadership | 1 | 2020 | 320 | 0.140 |
Why?
| Refractory Period, Electrophysiological | 1 | 2016 | 5 | 0.140 |
Why?
| Trigeminal Ganglion | 1 | 2016 | 22 | 0.140 |
Why?
| Hydrogels | 1 | 2023 | 596 | 0.140 |
Why?
| Evoked Potentials, Somatosensory | 1 | 2016 | 33 | 0.140 |
Why?
| Beneficence | 1 | 2016 | 19 | 0.140 |
Why?
| Surgeons | 1 | 2020 | 245 | 0.140 |
Why?
| Graft Survival | 3 | 2023 | 500 | 0.140 |
Why?
| Central Nervous System | 1 | 2017 | 244 | 0.140 |
Why?
| Lymphoproliferative Disorders | 1 | 2016 | 46 | 0.130 |
Why?
| Social Justice | 1 | 2016 | 63 | 0.130 |
Why?
| Education, Medical, Graduate | 1 | 2019 | 432 | 0.130 |
Why?
| Cervicoplasty | 1 | 2014 | 1 | 0.130 |
Why?
| Postoperative Care | 1 | 2016 | 245 | 0.130 |
Why?
| Neck Injuries | 1 | 2014 | 21 | 0.130 |
Why?
| Reaction Time | 1 | 2016 | 416 | 0.120 |
Why?
| Extracellular Matrix | 1 | 2018 | 461 | 0.120 |
Why?
| Feasibility Studies | 1 | 2016 | 780 | 0.120 |
Why?
| Swine | 3 | 2022 | 777 | 0.120 |
Why?
| Tissue and Organ Procurement | 1 | 2016 | 243 | 0.110 |
Why?
| Transplantation, Isogeneic | 2 | 2009 | 17 | 0.110 |
Why?
| Patient Selection | 1 | 2016 | 717 | 0.110 |
Why?
| Allografts | 2 | 2023 | 132 | 0.110 |
Why?
| Swine, Miniature | 2 | 2022 | 72 | 0.100 |
Why?
| Burns | 1 | 2014 | 256 | 0.100 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 2501 | 0.090 |
Why?
| Immune Tolerance | 2 | 2009 | 355 | 0.090 |
Why?
| Cyclosporine | 4 | 2013 | 175 | 0.090 |
Why?
| Facial Asymmetry | 1 | 2009 | 6 | 0.090 |
Why?
| Mandibulofacial Dysostosis | 1 | 2009 | 5 | 0.090 |
Why?
| Craniosynostoses | 1 | 2009 | 28 | 0.080 |
Why?
| Cleft Lip | 1 | 2009 | 37 | 0.080 |
Why?
| Nose | 1 | 2009 | 58 | 0.080 |
Why?
| Disease Models, Animal | 2 | 2016 | 3799 | 0.080 |
Why?
| Humans | 10 | 2023 | 122796 | 0.080 |
Why?
| Isoantibodies | 1 | 2009 | 64 | 0.080 |
Why?
| Cleft Palate | 1 | 2009 | 53 | 0.080 |
Why?
| Age Factors | 1 | 2016 | 3114 | 0.080 |
Why?
| Face | 1 | 2009 | 179 | 0.070 |
Why?
| Models, Animal | 1 | 2009 | 373 | 0.070 |
Why?
| Fascia | 1 | 2023 | 18 | 0.060 |
Why?
| Atrophy | 1 | 2023 | 167 | 0.060 |
Why?
| Abatacept | 1 | 2022 | 43 | 0.060 |
Why?
| Optic Nerve | 1 | 2022 | 66 | 0.050 |
Why?
| Rabbits | 1 | 2023 | 808 | 0.050 |
Why?
| Neoplasms | 1 | 2016 | 2235 | 0.050 |
Why?
| Sirolimus | 1 | 2022 | 198 | 0.050 |
Why?
| Chromatography, Liquid | 1 | 2022 | 356 | 0.050 |
Why?
| Transplantation, Heterotopic | 1 | 2020 | 16 | 0.050 |
Why?
| Macaca | 1 | 2020 | 53 | 0.050 |
Why?
| Mammals | 1 | 2022 | 257 | 0.050 |
Why?
| Schwann Cells | 1 | 2020 | 27 | 0.050 |
Why?
| Tandem Mass Spectrometry | 1 | 2022 | 423 | 0.050 |
Why?
| Internship and Residency | 2 | 2020 | 1065 | 0.040 |
Why?
| Maternal Health | 1 | 2019 | 45 | 0.040 |
Why?
| Delayed-Action Preparations | 1 | 2020 | 162 | 0.040 |
Why?
| Contrast Media | 1 | 2022 | 387 | 0.040 |
Why?
| Tissue Engineering | 1 | 2023 | 366 | 0.040 |
Why?
| Schools, Medical | 1 | 2020 | 152 | 0.040 |
Why?
| GAP-43 Protein | 1 | 2018 | 5 | 0.040 |
Why?
| Stem Cells | 1 | 2023 | 576 | 0.040 |
Why?
| Axons | 1 | 2020 | 185 | 0.040 |
Why?
| Intermediate Filaments | 1 | 2018 | 48 | 0.040 |
Why?
| Tensile Strength | 1 | 2018 | 100 | 0.040 |
Why?
| Glycosaminoglycans | 1 | 2018 | 81 | 0.040 |
Why?
| Elastomers | 1 | 2017 | 26 | 0.040 |
Why?
| Polyesters | 1 | 2017 | 66 | 0.040 |
Why?
| Needs Assessment | 1 | 2019 | 345 | 0.040 |
Why?
| Faculty, Medical | 1 | 2020 | 258 | 0.040 |
Why?
| Neovascularization, Physiologic | 1 | 2018 | 192 | 0.040 |
Why?
| Male | 7 | 2020 | 59639 | 0.030 |
Why?
| Hyaluronic Acid | 1 | 2018 | 203 | 0.030 |
Why?
| Societies, Medical | 1 | 2020 | 741 | 0.030 |
Why?
| Collagen | 1 | 2018 | 436 | 0.030 |
Why?
| Wound Healing | 1 | 2018 | 279 | 0.030 |
Why?
| Treatment Outcome | 2 | 2023 | 9692 | 0.030 |
Why?
| Back | 1 | 2014 | 10 | 0.030 |
Why?
| Tissue Expansion | 1 | 2014 | 6 | 0.030 |
Why?
| Cytokines | 1 | 2023 | 1928 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 2017 | 312 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6682 | 0.030 |
Why?
| Biocompatible Materials | 1 | 2018 | 373 | 0.030 |
Why?
| Child | 2 | 2014 | 19561 | 0.030 |
Why?
| Fetus | 1 | 2018 | 699 | 0.030 |
Why?
| Pulse Therapy, Drug | 1 | 2013 | 6 | 0.030 |
Why?
| Neural Conduction | 1 | 2013 | 82 | 0.030 |
Why?
| Sciatic Nerve | 1 | 2013 | 59 | 0.030 |
Why?
| United States | 2 | 2020 | 13272 | 0.030 |
Why?
| Muscular Atrophy | 1 | 2013 | 85 | 0.030 |
Why?
| Locomotion | 1 | 2013 | 84 | 0.030 |
Why?
| Gene Expression | 1 | 2018 | 1506 | 0.030 |
Why?
| Attitude of Health Personnel | 1 | 2019 | 1012 | 0.030 |
Why?
| Dexamethasone | 1 | 2013 | 323 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2022 | 3264 | 0.020 |
Why?
| Acute Disease | 1 | 2013 | 984 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2009 | 65 | 0.020 |
Why?
| Anti-Inflammatory Agents | 1 | 2013 | 469 | 0.020 |
Why?
| Rats, Inbred WF | 1 | 2009 | 5 | 0.020 |
Why?
| Antilymphocyte Serum | 1 | 2009 | 67 | 0.020 |
Why?
| Femoral Vein | 1 | 2009 | 29 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4734 | 0.020 |
Why?
| Administration, Topical | 1 | 2009 | 154 | 0.020 |
Why?
| Anastomosis, Surgical | 1 | 2009 | 151 | 0.020 |
Why?
| Femoral Artery | 1 | 2009 | 182 | 0.020 |
Why?
| Biomarkers | 1 | 2018 | 3662 | 0.020 |
Why?
| Pregnancy | 1 | 2019 | 5854 | 0.020 |
Why?
| Female | 3 | 2020 | 63629 | 0.020 |
Why?
| Risk Factors | 1 | 2019 | 9381 | 0.020 |
Why?
| Adult | 2 | 2019 | 32385 | 0.020 |
Why?
| Cohort Studies | 1 | 2014 | 5294 | 0.020 |
Why?
| Skin | 1 | 2009 | 694 | 0.020 |
Why?
| Postoperative Complications | 1 | 2013 | 2301 | 0.010 |
Why?
| Young Adult | 1 | 2014 | 11094 | 0.010 |
Why?
| Retrospective Studies | 1 | 2014 | 13433 | 0.010 |
Why?
| Adolescent | 1 | 2014 | 18948 | 0.010 |
Why?
|
|
Washington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|